Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04830592 |
|---|---|
| Brief Title: | A Study of NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and Neck (MOAT) |
| First Submitted : | March 31, 2021 |
| First Submitted that Met QC Criteria : | March 31, 2021 |
| First Posted : | April 5, 2021 |
| Last Update Submitted that Met QC Criteria : | April 6, 2021 |
| Last Update Posted : | April 9, 2021 |